Alceptor Therapeutics
- Biotech or pharma, therapeutic R&D
Alceptor Therapeutics is focused on the discovery and development of novel oral drugs primarily for neuropsychiatric disorders with high unmet needs. The efforts leverage unique insights and pharmacological approaches to the adrenergic system, which is clinically validated in multiple CNS disorders. More recent advances in the understanding of the pharmacology of this system provides the opportunity for improved therapies. The most advanced compounds are in toxicology studies and the first IND is targeted for early 2026.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}